Centre for Evaluation of Vaccination (CEV)
Background document (Pdf, 857 kB).
Tursday 11th of June 2020
Session 1: Welcome and opening of the meeting
Chairs: Pierre Van Damme & Greet Hendrickx
17:00 - 17:20
Session 2: Key messages of the presentations - Questions
Chair: Pierre Van Damme
17:20 – 17:30 Presentation 1: Experience with one dose in Latin America
Experience after Seven year of follow up and Statistical modelling alongside observational data predicts long-term immunogenicity of one dose and two doses of paediatric hepatitis A vaccine in the Mendoza province of Argentina.
Presentation 2: Experience with one dose in Asia
17:30 - 17:40 Presentation 3: Immune memory with one dose of hepatitis A vaccine – booster dose?
A single dose of inactivated hepatitis. A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection.
Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina.
Systematic literature review on efficacy/effectiveness of single dose hepatitis A paediatric vaccination programs
Eveline M. Bunge, PhD, Rosa C. van Hoorn, MSc (Pallas)
18:00 - 18:20
Data from CHINA - Xuan-Yi Wang
Hepatitis A activities in WHO - Christoph Steffen
Session 3: Groups Discussion
18:20 - 19:45 Statements to be discussed during the groups discussion
1. Is there enough scientific evidence to support one dose hepatitis A vaccination
(Chair: Daniel Shouval)
2. Can one dose be recommended in outbreak managements
(Chair: Sema Mandal)
3. Better one than no dose?
(Chair: Thomas Vanwolleghem)
4. Do we need a booster after one dose hepatitis A vaccination
(Chair: Vana Papaevangelou)
19:45 - 20:00 Closing of the meeting
The report of the meeting will be added later.